Here are relevant reports on : last-mile-delivery-market
-
Referral Management Market by Component (Software (Integrated, Standalone), Services), Delivery Mode (Cloud Based, On Premise), Type (Inbound, Outbound), End User (Providers, Payers) – Analysis & Global Forecasts to 2027
The global referral management market growth is primed to transition from USD 3.2 billion in 2022 to USD 6.1 billion by 2027, showcasing a strong CAGR of 13.6%. Growth in the referral management market can be attributed to factors such as technological advancements in healthcare facilitiesand risingadoption of referral management solutions by healthcare providers to offer better care delivery.
- Published: August 2022
- Price: $ 4950
- TOC Available:
-
Transdermal Drug Delivery System Market by Type (Patches and Semisolid formulations), Applications (Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Diseases), End User, and Region - Global Forecast to 2023
The transdermal drug delivery system market is projected to reach USD 7.1 billion by 2023, growing at a CAGR of 4.5%. The growth of this market is primarily driven by factors such as the increase in the prevalence of chronic diseases and technological advancements in transdermal drug delivery systems. The key players in the transdermal drug delivery systems market are Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (UK), Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).
- Published: January 2019
- Price: $ 4950
- TOC Available:
-
Cough Assisted Devices Market by product (Automatic Cough Assist Device, Manual Cough Assist Device), Choice of Delivery (Face Mask, Mouth Piece, Adopter), and End User (Hospitals, Homecare Settings) - Global Forecast to 2023
The global cough assist device market is expected to reach USD 226.5 million by 2023 from USD 150.6 million in 2018, growing at a CAGR of 8.5%. Increasing prevalence of chronic obstructive pulmonary disease (COPD) is the major factor that support the growth of the market. In addition to this, changing lifestyle such as smoking; and rising air pollution are the risk factors that support the growth of the cough assist devices during forecast period. On the other hand, rising awareness regarding advanced treatment method among patient population support the growth of the market. However, availability of alternative treatments is expected to hinder the market to a certain extent.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) - Global Forecast to 2024
The electronic drug delivery system market is expected to grow from USD 7.8 billion in 2019 to USD 11.9 billion by 2024, at a compound annual growth rate (CAGR) of 8.7%. during the forecast period.The prominent players in the electronic drug delivery systems market are Insulet Corporation (US), Bayer AG (Germany), Medtronic (Ireland), Novo Nordisk A/S (Denmark), Companion Medical (US), F.Hoffmann-La Roche Ltd (Switzerland), United Therapeutics Corporation (US), AstraZeneca (UK), Tandem Diabetes Care (US), Merck Group (Germany), and Amgen (US).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
Emergency Department Information System Market by Delivery Mode (On-Premise, Software as a Service), Software Type (Best-Of-Breed, Enterprise Solutions), Application (CPOE, Patient Tracking & Triage), End User – Global Forecast to 2019
The global emergency department information system (EDIS) market was valued at $312.68 million in 2014 and poised to grow at a CAGR of 15.24% between 2012 and 2019, to reach $635.50 million in 2019. The rapid increase in healthcare expenditure, increasing use of data-driven technologies, implementation of the HITECH Act, and rise in aging population will be the most important growth drivers for this market in the forecast period (2012–2019).
- Published: November 2014
- Price: $ 4950
- TOC Available:
-
Nanotechnology Drug Delivery System Market by Type, End-User, Industry, Application and Region - Global Forecast to 2030
The market for drug delivery systems that use nanotechnology to improve the delivery and targeting of medicinal medicines to certain areas within the body is referred to as the nanotechnology drug delivery system market. Drug delivery techniques based on nanotechnology solve problems with conventional approaches, such as low solubility, restricted bioavailability, and lack of specificity, by utilising nanoscale materials and structures.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Live Cell Encapsulation Market by Technique (Dripping (Simple, Electrostatic), Coaxial Airflow, Liquid Jet), Polymer (Alginate, Chitosan, Silica, Cellulose Sulfate), Application (Probiotics, Transplant, Drug Delivery, Research) - Forecast to 2024
The live cell encapsulation market is projected to grow to USD 303 million by 2024 from USD 250 million in 2018, at a CAGR of 3.2% during the forecast period. Growth in the live cell encapsulation market is primarily driven by factors such as the increasing public-private investments to support product development, increasing research to establish the clinical efficacy of cell encapsulation technologies, and rising public awareness related to the clinical role of encapsulated cells in disease management. BioTime, Inc. (US), Viacyte, Inc. (US), and Living Cell Technologies Ltd. (Australia) were the top three players in the live cell encapsulation market. Other prominent players operating in this market include Sigilon Therapeutics, Inc. (US), Evonik Industries (Germany), BÜCHI Labortechnik AG (Germany), Blacktrace Holdings Ltd (UK), and Sernova Corporation (Canada), among others. Furthermore, the key players in the developmental pipeline products in this market include Neurotech Pharmaceuticals, Inc. (US), Gloriana Therapeutics (US), Kadimastem (Israel), Beta-O2 Technologies, Inc. (Israel), Defymed (France), and Altucell, Inc. (US), among others.
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Healthcare Fraud Analytics Market by Solution Type (Descriptive, Predictive, Prescriptive), Application (Insurance Claim, Payment Integrity), Delivery (On-premise, Cloud), End User (Government, Employers, Payers) & Region - Global Forecast to 2026
The global healthcare fraud analytics market growth is primed to transition from $1.5 billion in 2021 to $5.0 billion by 2026, showcasing a strong CAGR of 26.7%. The market is driven by the rise in fraudulent healthcare activities, an increasing number of patients seeking health insurance, and the rising number of pharmacy claims-related frauds.
- Published: October 2021
- Price: $ 4950
- TOC Available:
-
Needles Market by Type (Conventional (Bevel, Vented) & Safety), Product (Suture, Blood Collection, Insufflation), Material (Stainless Steel, Plastic), Delivery Mode (IV, IM, Hypodermic), End-User (Hospitals, Diagnostic Centres) & Region - Global Forecast to 2027
The global needles market growth is primed to transition from billion USD 7.7 in 2022 to USD 10.6 billion by 2027, showcasing a strong CAGR of 6.7%. The expansion of this market is majorly due to upsurging cases of chronic diseases such as cancer, HIV as well as growing elderly population. However, Growing focus on core development of substitute drug delivery methods is one of the challenge for which may inhibit the growth of this market.
- Published: November 2022
- Price: $ 4950
- TOC Available:
-
Laboratory Information System (LIS) Market by Product (Standalone, Integrated), Component (Services, Software), Delivery Mode (On-premise & Cloud-based), End User (Hospital Laboratories, Independent Laboratories, POLs) and Region - Global Forecast to 2028
The global laboratory information system market, valued at US$2.0 billion in 2022, stood at US$2.4 billion in 2023 and is projected to advance at a resilient CAGR of 10.8% from 2023 to 2028, culminating in a forecasted valuation of US$4.0 billion by the end of the period. The expansion of molecular diagnostic techniques, including genomics and personalized medicine, and the need for automation and robotics in laboratories primarily drive the market growth.
- Published: July 2023
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50